Peptide Advocate
Back to Longevity

/ Peptide Advocate

October 22, 2026

Not FDA-Approved4/10 · Low

The GLOW Blend: What the Science Really Says About the “Glow” Peptide Stack

GLOW pairs GHK-Cu, a copper peptide with a long skin-care history, with BPC-157 and TB-500. Here’s what the science shows, why injecting copper peptide isn’t the same as using a cream, and where GLOW stands with the FDA.

The GLOW blend: What the science really says about the "glow" peptide stack

GLOW is a popular injectable peptide blend promoted for glowing skin, healthy hair and faster recovery. It mixes a well-known skin-care peptide, GHK-Cu, with two "healing" peptides, BPC-157 and TB-500. Each has an interesting backstory, but the blend has never been tested. Here's what the science shows, why injecting isn't the same as using a skin cream, and where GLOW stands with the FDA.

Peptide Advocate · Research explainer · Updated October 2026

What it isAn injectable mix of GHK-Cu, BPC-157 and TB-500, sold as a "research" product1
Why people are interestedGHK-Cu's skin-care reputation plus BPC-157 and TB-500's "healing" buzz1,2
Human evidenceNone for the blend, and no trials of injected GHK-Cu1
Legal statusNot FDA-approved, and not eligible for U.S. compounding as an injectable blend1

What is GLOW?

GLOW is a market name, not a drug or a standard formula. It combines three peptides in one vial, in ratios that vary by seller. A related blend, KLOW, adds a fourth peptide, KPV.1

What's in GLOW GLOW combines GHK-Cu, BPC-157, TB-500. GHK-Cu: Copper-carrying peptide found naturally in blood. BPC-157: 15-amino-acid fragment of a stomach protein. TB-500: Lab-made piece of thymosin beta-4, a natural repair protein. What's in GLOW 3 separate peptides mixed in one vial. Ratios vary by seller. GHK-Cu Copper-carrying peptide found naturally in blood BPC-157 15-amino-acid fragment of a stomach protein TB-500 Lab-made piece of thymosin beta-4, a natural repair protein
Illustration: Peptide Advocate.

Why people are interested

GLOW's name says it all: it's marketed for skin. The star ingredient is GHK-Cu, a small copper-carrying peptide your body makes naturally. It was first described in 1973, and lab research links it to collagen production, wound repair and skin remodeling.1,2 Copper peptides have been used in skin-care creams for years.

The other two ingredients, BPC-157 and TB-500, are promoted for repairing tendons, muscles and other tissues based on animal studies.4 The pitch is that together they'll help skin, hair and recovery all at once.

What about people?

The evidence is much thinner than the marketing suggests:

  • GHK-Cu on the skin. Most of its skin findings come from lab and animal studies. A 2025 review found surprisingly few clinical studies of copper peptide skin products, and in a small 13-patient trial on laser-treated skin, the measurable results weren't significantly different between groups.1
  • GHK-Cu by injection. No trial has tested injected GHK-Cu.1
  • BPC-157 and TB-500. No completed human trials for healing; the evidence is from animals and lab studies.4
  • The blend. No study has tested GHK-Cu, BPC-157 and TB-500 together, in animals or people. The only related study, a small 2026 rat study, found BPC-157 plus TB-500 did no better than either alone.1,3
How much is known about GLOW Each ingredient has been tested in animals separately. Only BPC-157 and TB-500 have been tested together, in one small rat study. The blend has never been tested in people, and there are no public standards for its stability or purity. What's known about the blend itself Evidence for single ingredients doesn't automatically carry over to a mix Each ingredient tested in animals Yes, separately ~ Ingredients tested together in animals Only BPC-157 + TB-500, in one small rat study Blend tested in people Never Blend checked for stability and purity No public standards; varies by seller
Sources: published research reviews.1,3 Illustration: Peptide Advocate.
The only study of BPC-157 and TB-500 together In a 2026 rat study of Achilles tendon repair, with 4 rats per measurement, TB-500 alone improved tendon strength and both tissue scores compared with untreated rats. BPC-157 alone improved neither strength nor these tissue scores. The combination improved one tissue score and did no better than either peptide alone. Two peptides, no added benefit Rat Achilles tendon repair, 2026. Better than untreated rats? BPC-157 alone TB-500 alone Both together Tendon strength – – Tissue organization (Bonar score) – – Tissue organization (Movin score) – Only 4 rats per measurement, one time point. ✓ = statistically better than untreated rats; – = no significant difference.
Source: Biçer et al., Joint Diseases and Related Surgery, 2026.3 Illustration: Peptide Advocate.

Here's where each ingredient stands on its own:

IngredientPromoted forBest evidenceFDA statusAthletes (WADA)
GHK-CuSkin, collagen and hairLab and animal studies; a few small skin-cream studies; no injection trials1Allowed in non-injectable forms; injectable form awaiting FDA advisory review1Not specifically named; skin-care use generally not a concern8
BPC-157Tendon, muscle and gut healingAnimal studies; no completed human trials4Advisers voted 8–6 in July 2026 to recommend compounding (for ulcerative colitis); FDA decision pending5Banned by name8
TB-500Wound, tendon and muscle repairAnimal studies; no completed human trials4Advisers voted 8–6 in July 2026 to recommend compounding (for wound healing); FDA decision pending5Banned by name8
1973year GHK-Cu was first described1
3peptides in one vial, in ratios that vary by seller1
0human trials of the GLOW blend or of injected GHK-Cu1
2 of 3ingredients banned by name for athletes8

Is GLOW safe?

No one knows, because the blend has never been tested. What we can say:

  • A skin cream isn't an injection. Copper peptides in skin-care products sit on the surface. Injecting GHK-Cu puts copper peptide directly into the body, and that route hasn't been studied.1
  • Unknown interactions. No one has studied whether these peptides affect one another or whether the mixture stays stable in the vial.1
  • Injection risks. Injecting unregulated products risks infection and contamination, and one non-peer-reviewed report found bacterial toxins in peptide products.4
  • Theoretical cancer concern. BPC-157 and TB-500 may promote new blood vessel growth, which some experts worry could feed existing tumors. This hasn't been studied in people.4
  • Reported side effects. Users describe injection-site irritation, stomach upset, tiredness and headaches, but these are informal reports.4
  • No quality control. GLOW is sold as a "research chemical," with no verified purity, strength or sterility.1
Athletes: BPC-157 and TB-500 are both banned by name by the World Anti-Doping Agency, so any GLOW product could cause a failed drug test, even if you're using it for your skin.8

Where GLOW stands with the FDA

GLOW is not FDA-approved. As an injectable blend, it isn't eligible for U.S. compounding, because none of its ingredients is on the FDA's approved list in injectable form.1 GHK-Cu is allowed in compounded products that aren't injected, such as creams.1 In April 2026, BPC-157, TB-500 and injectable GHK-Cu were removed from the FDA's restricted "Category 2" list. In July, FDA advisers voted 8–6 to recommend BPC-157 and TB-500 for compounding. Injectable GHK-Cu is still waiting for its review.6,5,7

How GLOW's ingredients have changed status

  1. Before 2026BPC-157, TB-500 and injectable GHK-Cu sit on the FDA's restricted Category 2 list6
  2. April 2026All three are removed from Category 2 after their nominations are withdrawn. The FDA didn't find them safe6,1
  3. July 23, 2026FDA advisers vote 8–6 to recommend BPC-157 and TB-500 for compounding, against FDA staff advice5
  4. September 2026FDA sends warning letters to online sellers of unapproved "research" peptides9
  5. October 15, 2026HHS sends an "interim access policy" for certain peptides to the White House10
  6. NextFDA decisions on the July votes; advisory review of injectable GHK-Cu expected by early 20277

Even if each ingredient is eventually approved for compounding, that won't make a three-in-one blend a tested product. We'll update this article as the rules change.

If you're curious about GLOW

  • Want healthier skin? Sunscreen, retinoids and a dermatologist's advice have strong evidence. Copper peptide creams are widely available as cosmetics.
  • Thinning hair? See a doctor or dermatologist. Several proven treatments exist.
  • Recovering from an injury? A sports medicine doctor or physical therapist can help.
  • Skip "research use only" injectables. They aren't made for people, and contents can't be verified.
  • Tell your doctor about any peptides you use.

The bottom line

GLOW borrows the good reputation of copper peptide skin care and adds two buzzy "healing" peptides, but the science doesn't follow it into the vial. Copper peptides have a long history in creams, yet even there the clinical evidence is thin, and injecting GHK-Cu has never been tested. BPC-157 and TB-500 rest on animal studies, and the full blend has never been studied in anyone. For glowing skin, the proven basics still win. GLOW is a marketing idea, not a tested treatment.

References

  1. Superpower. GLOW peptide blend: GHK-Cu, BPC-157 and TB-500, and how KLOW differs; updated September 28, 2026. superpower.com
  2. Pickart L, Margolina A. Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data. Int J Mol Sci. 2018;19(7):1987. pubmed.ncbi.nlm.nih.gov
  3. Biçer O, Adanir O, Güleryüz Y, et al. Effects of BPC-157 and TB-500 on Achilles tendon healing in rats: a histopathological and biomechanical study. Jt Dis Relat Surg. 2026;37(3):822–837. jointdrs.org
  4. Healthline. Wolverine peptides: what to know; updated October 14, 2026. healthline.com
  5. American Med Spa Association. FDA advisory committee recommends adding six of seven peptides to compounding list; July 2026. americanmedspa.org
  6. 503Pharma. FDA pulls 12 peptides from Category 2 list; April 2026. beehiiv.com
  7. Biotech Research. FDA schedules July PCAC review for seven peptides as Category 2 compounding restrictions lapse; May 5, 2026. biotechresearch.co.uk
  8. Peptide Journal. Peptides and WADA: anti-doping rules for athletes; November 2025. peptidejournal.org
  9. Pharmaceutical Technology. FDA cracks down on black market peptide trade; September 2, 2026. pharmaceutical-technology.com
  10. Associated Press. Trump administration advances plan for peptide drugs favored by RFK Jr. ABC News; October 15, 2026. abcnews.com

This article is for general education and is not medical advice. GLOW and its ingredients are not approved by the FDA to diagnose, treat, cure or prevent any condition, and this article does not recommend using them or provide dosing information. Talk with a licensed healthcare provider before starting any new treatment. Regulatory information is current as of October 16, 2026 and is changing quickly. Charts and illustrations are original works by Peptide Advocate.